Hysterosalpingography for assessing efficacy of Essure microinsert permanent birth control device.
OBJECTIVE
The Essure microinsert is a new U.S. Food and Drug Administration-approved method of birth control. The objective of this study is to report our initial experience using hysterosalpingography (HSG) to assess its efficacy for permanent tubal occlusion.


CONCLUSIONS
The Essure microinsert produced tubal blockage in all patients. As this device may become more widely used, radiologists should be aware of the device's appearance and be able to assess device position and presence of tubal occlusion on HSG.
Wittmer
Michael H
MH
Department of Radiology, Mayo Clinic, 200 1st St., SW, Rochester, MN 55902, USA.
Famuyide
Abimbola O
AO
Creedon
Douglas J
DJ
Hartman
Robert P
RP
D000328:Adult; D003274:Contraceptive Devices, Female / Q000009:adverse effects; D005187:Fallopian Tubes; D005260:Female; D006801:Humans; D007047:Hysterosalpingography; D008875:Middle Aged; D019736:Prostheses and Implants; D013246:Sterilization, Tubal / Q000295:instrumentation*